Catalent | CTLT - Debt


Catalent reported $4.95B in Debt for its fiscal quarter ending in September of 2024.



Debt Change Date
Agilent USD 3.35B 55M Sep/2025
AstraZeneca USD 32.63B 207M Sep/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Bruker USD 2.01B 426.8M Sep/2025
Centene USD 17.58B 6M Sep/2025
Charles River Laboratories USD 2.63B 157.4M Sep/2025
Cigna USD 34.04B 3.27B Sep/2025
Danaher USD 18.42B 1.56B Dec/2025
Dentsply International USD 2.48B 14M Sep/2025
Elevance Health USD 32.05B 56M Dec/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Glaxosmithkline GBP 17.75B 396M Sep/2025
Hologic USD 2.63B 104.3M Sep/2025
Humana USD 12.37B 238M Dec/2025
Illumina USD 2.58B 22M Sep/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
J&J USD 45.8B 4.97B Sep/2025
Laboratory Of America USD 6.53B 16.1M Sep/2025
Lonza CHF 4.71B 915M Dec/2024
McKesson USD 9.79B 141M Sep/2025
Merck EUR 12.1B 2.7B Sep/2025
Merck USD 41.37B 5.97B Sep/2025
Mettler Toledo International USD 2.21B 25.94M Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Quest Diagnostics USD 6.38B 2M Sep/2025
Repligen USD 542.21M 146.65M Dec/2025
Revvity USD 3.37B 5.86M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Supernus Pharmaceuticals USD 42.21M 10.44M Sep/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
UnitedHealth USD 78.39B 1.75B Dec/2025
Veradigm USD 200.33M 431K Sep/2022
Waters USD 1.49B 52.2M Sep/2025
West Pharmaceutical Services USD 202.8M 100K Dec/2025